Pattern Analysis of Hb Variants by HPLC & its Clinico-Haematological Correlation in The Tertiary Health Care Centre of Northern Odisha, India

Read full text Summarise with VIRAT
Authors: Bandana Mishra, Binaya Bhushan Bihari, Disha Ray, M. Faisal, Prabhudatta Dash, Asaranti Kar
Cited by: 0
References: 9

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Thalassemia and hemoglobinopathies are major health problems associated with significant morbidity and mortality in the Indian population. Hemoglobinopathies are inherited in an autosomal recessive manner and affect globin chains. Thalassemia is characterised by the absence or reduced synthesis of one or more globin chains. Sickle cell disease is the most common hemoglobinopathy, accounting for 7% of the world's population. Different Hb variants are relatively common in India compared to global data. Analysis of Hb variants by the HPLC method can help estimate the magnitude of the disorder and assist in early diagnosis and prevention through genetic counselling. This study aims to detect Hb variants using the HPLC technique and to determine the prevalence of hemoglobinopathies as well as their correlation with clinicohematological parameters. This study was conducted over the last two years in our tertiary care centre. The HPLC findings of Hb fractions were correlated with haematological parameters and clinical profiles. The results revealed that out of a total of 1,394 cases in the study, 326 had abnormal Hb variants. The most common Hb variant was β-thalassemia trait, accounting for 153 cases, followed by sickle cell trait with 71 cases, and 11 cases of β-thalassemia major. Other hemoglobinopathy cases included 20 cases of HbE trait, 21 cases of HbE homozygous, 20 cases of homozygous sickle cell disease, 2 cases of hereditary persistent fetal haemoglobin (HPFH), and 1 case of Hb Lepore. There were 27 cases of compound heterozygotes: 22 of which were for sickle cell/β-thalassemia, 4 for HbE/βthalassemia, and 1 case of HbS/D trait.

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Iron Metabolism and Disorders Blood groups and transfusion

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
02
Publication date
28 February 2026
Language
EN